Ryan Maves to Anti-HIV Agents
This is a "connection" page, showing publications Ryan Maves has written about Anti-HIV Agents.
Connection Strength
0.343
-
Aldrete S, Jang JH, Easley KA, Okulicz J, Dai T, Chen YN, Pino M, Agan BK, Maves RC, Paiardini M, Marconi VC. CD4 rate of increase is preferred to CD4 threshold for predicting outcomes among virologically suppressed HIV-infected adults on antiretroviral therapy. PLoS One. 2020; 15(1):e0227124.
Score: 0.172
-
Joya C, Won SH, Schofield C, Lalani T, Maves RC, Kronmann K, Deiss R, Okulicz J, Agan BK, Ganesan A. Persistent Low-level Viremia While on Antiretroviral Therapy Is an Independent Risk Factor for Virologic Failure. Clin Infect Dis. 2019 11 27; 69(12):2145-2152.
Score: 0.171